QTTB vs JBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 07, 2026

QTTB

38.4
AI Score
VS
JBIO Wins

JBIO

44.5
AI Score

Investment Advisor Scores

QTTB

38score
Recommendation
SELL

JBIO

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric QTTB JBIO Winner
Net Income -53.70M -96.13M QTTB
Operating Income -48.26M -102.36M QTTB
ROE 29.4% -21.9% QTTB
ROA -114.1% -20.4% JBIO
Total Assets 47.06M 472.11M JBIO
Cash 25.62M 107.25M JBIO
Current Ratio 2.04 14.93 JBIO
Free Cash Flow -18.68M -67.93M QTTB

Relative Price Performance (Last 90 Days)

QTTB 1M: +13.8% · 3M: -40.3% JBIO 1M: +24.9% · 3M: -29.6%

Current Technical Phase

QTTB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 51.8 · Price: $9.18

JBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 64

RSI (14): 64.1 · Price: $16.76

Fundamentals Snapshot

Metric QTTB JBIO
Market Cap — —
Forward P/E -4.3 -6.2
Trailing P/E 2.6 —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.7% —
Operating Margin 0.3% 0.0%
EPS 3.60 -1.92
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, JBIO is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.